Masafumi Yamato - Publications

Causal Effects of Early Discontinuation of Proton Pump Inhibitors on Kidney Failure.

Journal: Kidney international reports

Published: June 18, 2026

Discontinuing renin-angiotensin system inhibitors after incident hyperkalemia and clinical outcomes: target trial emulation.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: February 05, 2025

Seasonal variations in the association between proteinuria and kidney failure.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 04, 2024

Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 03, 2024

Diabetic nephropathy with marked extra-capillary cell proliferation: a case report.

Journal: BMC nephrology

Published: March 05, 2023

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD.

Journal: Scientific reports

Published: December 04, 2022

Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics.

Journal: Internal medicine (Tokyo, Japan)

Published: February 03, 2022

Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: June 12, 2020

User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.

Journal: BMC nephrology

Published: May 07, 2020

Continuous Hemodiafiltration with an AN69ST Hemofilter (AN69ST-CHDF) as FGF-23-Lowering Therapy.

Journal: Clinical laboratory

Published: February 07, 2017

The Superiority of AN69ST Membrane in the Adsorption of Fibroblast Growth Factor-23.

Journal: Clinical laboratory

Published: March 26, 2016

Abnormal Diurnal Patterns of Parathyroid Hormone are Associated with Sustained Mild Hypercalcemia in Non-Dialyzed Chronic Kidney Disease.

Journal: Clinical laboratory

Published: March 26, 2016